| Serial Number | 97364220 |
| Word Mark | FMT |
| Filing Date | Thursday, April 14, 2022 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Thursday, June 22, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 22, 2022 |
| Goods and Services | Nutraceuticals, namely, epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; nutraceuticals, namely, epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer |
| Goods and Services | Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with research and development in the pharmaceutical and biotechnology fields, research and development in the field of epigenetic drugs, and research and development in the field of cancer treatment, diagnosis, detection, and prevention |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Thursday, June 22, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Thursday, June 22, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | L-Nutra Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Plano, TX 75024 |
| Party Name | L-Nutra Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Plano, TX 75024 |
| Event Date | Event Description |
| Thursday, June 22, 2023 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Thursday, June 22, 2023 | ABANDONMENT - AFTER PUBLICATION |
| Wednesday, June 21, 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Friday, May 12, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, January 17, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 22, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, October 17, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, October 7, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, October 7, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, October 7, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, October 7, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 26, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 26, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, September 26, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 26, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 21, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, June 8, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, June 8, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, June 8, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, April 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 18, 2022 | NEW APPLICATION ENTERED |